Full room at the 2nd edition of the Hands On CBR Course, which addressed Interstitial Lung Diseases

After discussing the theme “Pancreas” in its first edition, held in December 2018, the Hands On CBR Course took place again, now addressing “Lung Interstitial Diseases”. The activity, held last Saturday (16), included a theoretical context related to the most recent consensus on interstitial pneumonia and idiopathic pulmonary fibrosis. Approximately 25 cases could be evaluated and discussed by the participants, who used individual computers and discussed their doubts directly with the professors, providing an even more direct interaction, with in-depth analysis. The objective of the course was to update radiologists regarding the latest consensus of the international societies of Pulmonology, Radiology and Pathology regarding interstitial pneumonia and idiopathic pulmonary fibrosis, guiding the interpretation and communication of data, considering the emergence of new treatments and the role of the radiologist in the multidisciplinary discussion. The Doctor. Julião Bezerra, a radiologist from Rio Grande do Norte who participated in the course, highlighted the organization and didactic form of the hands-on model as an ally in updating medical practice. “There's the theoretical part, which reminds us of concepts that may be dormant or forgotten, new information, since learning is continuous, and the way we participate, seeing cases along with the theory. This fixes the knowledge even more”, he said. The activity was organized by Dr. Dante Escuissato, Master in Internal Medicine from the Federal University of Paraná (UFPR) and Doctor in Medicine (Radiology) from the Federal University of Rio de Janeiro (UFRJ), with the participation of Drs. Alexandre Mançano, Pablo Rydz, Arthur Soares and Pedro Torres. “In addition to expanding the horizon in the interpretation and formulation of the differential diagnosis of CT patterns in the aforementioned diseases, this course aims to update the role of the radiologist within multidisciplinary groups focused on patient care, including therapeutic guidance, since at the moment new drugs are being used in the management of idiopathic pulmonary fibrosis”, explains Dr. Dante Escuissato.